Peter Hanlon

JAMA

@jama.com

Does age or sex make a difference in how well newer glucose-lowering drugs work in patients with type 2 diabetes?

SGLT2 inhibitors may be more effective in reducing cardiovascular events in older adults with type 2 #diabetes.

➡️ Read more: ja.ma/3Cqvk7z

#MedSky

1 4 11

by Peter Hanlon

Peter Hanlon

@peterhanlon.bsky.social

Our new paper in @jama.com on age and sex differences in efficacy of type 2 diabetes treatments. It shows that older age is associated with greater cardiovascular benefits of SGLT2 inhibitors despite smaller improvement in HbA1c compared to younger people.

jamanetwork.com/journals/jam...

Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes

This network meta-analysis assesses whether age or sex are associated with differences in the efficacy of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipe...

jamanetwork.com

2

Reposted by: Peter Hanlon

School of Health and Wellbeing, University of Glasgow

@uofgshw.bsky.social

GP practices in deprived areas should be prioritised for resource, in order to allow them to provide effective care to some of the most unwell and vulnerable patients in society.

New study by Dr Marianne McCallum, Prof Sara Macdonald and @francesmair.bsky.social

www.gla.ac.uk/news/headlin...

A male doctor is writing notes in a consultation with a male patient.

1 6 12

References

Fields & subjects